# OnCo record philogen-s-p-a (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/philogen-s-p-a/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "philogen-s-p-a" ;
  schema:name "Philogen S.p.A."@en ;
  schema:description "Philogen S.p.A. is a Italy-based biotechnology company running 8 late-stage cancer trials of Onfekafusp alfa and onfekafusp alfa in melanoma, glioma & glioblastoma and basal cell carcinoma."@en ;
  schema:url <https://onco.cc/companies/philogen-s-p-a/>, <https://www.philogen.com> ;
  schema:dateModified "2026-09-11"^^xsd:date ;
  schema:citation <https://www.philogen.com>, <https://clinicaltrials.gov/search?lead=Philogen%20S.p.A.> ;
  onco:tag "ctgov-sponsor" ;
  schema:addressCountry "IT" ;
  onco:cancers <https://onco.cc/cancers/melanoma/>, <https://onco.cc/cancers/glioblastoma/>, <https://onco.cc/cancers/basal-cell-carcinoma/>, <https://onco.cc/cancers/sarcoma/> ;
  onco:trials <https://onco.cc/trials/nct06284590/>, <https://onco.cc/trials/nct04733183/>, <https://onco.cc/trials/nct07227870/>, <https://onco.cc/trials/nct02938299/>, <https://onco.cc/trials/nct07227350/>, <https://onco.cc/trials/nct03567889/>, <https://onco.cc/trials/nct04443010/>, <https://onco.cc/trials/nct06336291/> .